查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828153

2025年兒科介入性心臟病學全球市場報告

Pediatric Interventional Cardiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，兒科介入性心臟病學市場規模強勁成長，從2024年的24.4億美元增加至2025年的26億美元，複合年成長率為6.3%。預測期內的成長可歸因於人們對黴菌毒素認知的提高、監管標準更加嚴格、對動物健康的關注、家禽生產的全球化、市場競爭力的提升以及農場生產力的提高。

預計未來幾年兒科介入性心臟病學市場規模將強勁成長，到2029年將達到35.9億美元，複合年成長率為8.4%。預測期內的成長可歸因於家禽業的成長、氣候變遷的影響、對有機產品的需求、全球貿易動態、政府舉措以及日益增強的健康意識。預測期內的主要趨勢包括技術整合、飼料品質和安全、市場整合、合作研究、農業數位化以及飼料技術的進步。

小兒介入性心臟病學利用心導管手術，以微創方式診斷和治療兒童先天性心臟疾病。這些手術旨在以最小的外科干預治療各種心臟疾病。

兒童介入性心臟病學的關鍵器械包括封堵器、經導管心臟瓣膜、動脈粥狀硬化斑塊切除術器、導管、球囊和支架。閉合裝置包含多種配件，當它們被緊緊固定在閉合位置時，可以密封血管內或其外部的開口，從而減輕或防止排放。兒童介入性心臟病學的關鍵程序包括導管瓣膜植入術、先天性心臟疾病矯正術、血管成形術、冠狀動脈血栓切除術和其他方法。這些程序應用於臨床實驗室、醫院、心臟中心、兒科診所和研究機構，對兒童心臟病的診斷和治療做出了重要貢獻。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供兒科介入心臟病學市場統計數據，例如全球市場規模、區域佔有率、兒科介入心臟病學市場佔有率的競爭對手、詳細的兒科機構心臟病學細分市場、市場趨勢和機遇，以及您在兒科介入行業取得成功所需的數據。這份兒科介入心臟病學市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年8.4%的預測成長率比我們先前對該市場的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響將直接影響美國，導致主要從荷蘭和日本進口的導管導引線和球囊擴張型支架成本上升，並可能影響兒童微創心血管手術。此外，由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛。

隨著先天性心臟疾病（一種從出生起就影響心臟結構的疾病）的發生率不斷上升，兒科介入性心臟病學市場可望持續成長。與傳統的開心手術相比，這些手術具有恢復更快、感染風險更低、疤痕更小等優勢。根據美國心臟協會 2022 年的數據，美國約有 4 萬名嬰兒將患有先天性心臟疾病，預計每 1,000 名活產嬰兒中就有 12.3 名患有先天性心臟病。此外，《柳葉刀》在 2022 年報告稱，先天性心臟疾病是最常見的出生缺陷，每 1,000 名新生兒中就有近 9 名患有先天性心臟病。預計這種患病率將推動兒科介入性心臟病學市場的成長。

未來幾年，兒科族群將推動兒科介入性心臟病學市場的發展。兒科族群指的是特定年齡層的個體，通常指兒童期和青少年期。根據聯邦兒童與家庭統計跨部門論壇的數據，預計到2022年，美國兒童數將達到約7,250萬，到2050年將達到7,820萬。預計各年齡層人口的不斷成長將推動兒科介入性心臟病學手術的需求。

產品創新是兒科介入性心臟病學市場的關鍵趨勢。該領域的主要企業正在推出新的創新解決方案，以增強其市場佔有率。例如，2023 年 2 月，美國醫療設備製造商美敦力公司推出了 Harmony 經導管肺動脈瓣系統，這是一款經導管肺動脈瓣。該系統作為開胸手術的微創替代方案，可透過腿部或頸部的小切口植入。 Harmony TPV 系統專為接受過先天性心臟疾病手術且因先前植入的導管或生物假體肺動脈瓣而導致右心室流出道 (RVOT) 功能障礙的患者設計。它也適用於需要進行肺動脈瓣置換術的天然或貼片右心室流出道患者。

為了確保競爭優勢，兒科介入性心臟病學市場的主要企業正在優先開發3D食道超音波心動圖 (3D TEE) 等技術創新。在兒科介入性心臟病學中，即時 3D TEE 可提供先天性心臟疾病的複雜影像，包括心房中隔缺損和心室中隔缺損，這使其成為規劃和指導微創手術的關鍵。例如，2024 年 1 月，總部位於荷蘭的醫療技術公司飛利浦推出了 X11-4T Mini 3D TEE 換能器。這種尖端換能器透過提供診斷兒科先天性心臟疾病所必需的詳細影像，增強了3D食道超音波心動圖 (TEE)。其顯著特點包括緊湊的設計，可提高兒科患者的可操作性，高解析度成像功能，可提高診斷準確性，並可與現有的超音波心動圖系統相容，實現無縫的工作流程。這些進步將顯著改善兒科循環系統領域的治療結果和患者照護。

2022年2月，美國知名生物醫學和生物技術公司波士頓科學公司（Boston Scientific Corporation）以約17.5億美元的價格完成了對貝利斯醫療公司的收購。這項策略性舉措旨在鞏固波士頓科學公司在心臟病學市場的地位，尤其是在提供基於導管的左心室手術先進解決方案方面。貝利斯醫療公司也總部位於美國，專注於心臟病學、血管內治療和腫瘤學等高科技領域的尖端醫療設備。

兒科介入心臟病學市場的主要企業包括美敦力公司、通用電氣醫療技術公司、雅培實驗室、泰爾茂​​公司、戈爾公司、波士頓科學公司、愛德華生命科學公司、西門子醫療、Numed公司、聖猶達醫療公司、Cordis公司、荷蘭皇家飛利浦公司、百多力、B. Braips NV、百多力、B. Braunsungen AG、佳能醫療系統公司、戈爾公司、強生公司、庫克集團、泰利福公司、Merit醫療系統公司、微創醫療科學公司、樂普醫療技術（北京）有限公司、柏盛國際Group Limited、心臟科學公司、朝日Intecc公司、Medinol有限公司、Jotec有限公司、Hexacath有限公司和Translumina有限公司

2024年，北美是兒科介入性心臟病學市場最大的地區。預計在預測期內，亞太地區將成為全球兒科介入性心臟病學市場成長最快的地區。兒科介入性心臟病學市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

兒科介入性心臟病學市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙

兒科介入性心臟病學市場包括營業單位從經皮冠狀動脈介入治療服務、心房中膈缺損症服務、心導管插入術服務和經導管主動脈瓣置換服務中產生的收益。市場價值包括服務提供者銷售的或包含在服務產品中的相關商品的價值。僅包括在企業之間交易或出售給最終消費者的商品和服務。兒科介入性心臟病學市場還包括斑塊修改裝置、導管導引線、血管閉合裝置和動脈粥狀硬化斑塊切除術硬化切除裝置的銷售。該市場中的價值是「工廠門口」價值，即商品製造商或生產商直接向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或最終消費者銷售的商​​品價值。該市場中的商品價值也包括商品製造商銷售的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球兒科介入性心臟病學：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球兒科介入性心臟病學市場：成長率分析
  • 全球兒科介入性心臟病學市場表現：規模與成長，2019-2024
  • 全球兒科介入性心臟病學市場預測：規模與成長，2024-2029年，2034年
  • 全球兒科介入性心臟病學：總目標市場（TAM）

第6章 市場細分

  • 全球兒科介入性心臟病學市場（按設備類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 封閉裝置
  • 經導管心臟瓣膜
  • 動脈粥狀硬化斑塊切除術切除裝置
  • 導管
  • 氣球
  • 支架
  • 其他設備類型
  • 全球兒科介入性心臟病學市場（按程序、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 導管輔助瓣膜植入
  • 先天性心臟疾病的矯正
  • 血管成形術
  • 冠狀動脈血栓切除術
  • 其他措施
  • 全球兒科介入性心臟病學市場最終用途、績效及預測（2019-2024、2024-2029、2034）
  • 臨床檢測實驗室
  • 醫院
  • 心臟中心
  • 小兒科診所
  • 研究所
  • 全球兒科介入性心臟病學市場：按封堵器細分（按類型）、業績及預測，2019-2024 年、2024-2029 年、2034 年
  • 心房間隔缺損 (ASD) 封堵器
  • 室間隔缺損 (VSD) 封堵器
  • 開放性動脈導管(PDA) 封堵器
  • 全球兒科介入性心臟病學市場：經導管心臟瓣膜細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 經導管主動脈瓣置換術（TAVR）裝置
  • 經導管二尖瓣瓣膜修復裝置
  • 經導管肺動脈瓣置換裝置
  • 全球兒科介入性心臟病學市場：動脈粥狀動脈粥狀硬化斑塊切除術設備細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 定向動脈粥狀硬化斑塊切除術裝置
  • 旋動脈粥狀硬化斑塊切除術裝置
  • 雷射動脈粥狀硬化斑塊切除術裝置
  • 全球兒科介入性心臟病學市場：導管細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷導管
  • 治療導管
  • 引導管
  • 全球兒科介入性心臟病學市場：按球囊類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 球囊血管成形術球囊
  • 主動脈內球囊
  • 高壓氣球
  • 全球兒科介入性心臟病學市場：按支架類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型支架
  • 裸金屬支架
  • 生物可吸收支架
  • 全球兒科介入性心臟病學市場：按設備類型（其他）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 血管閉合裝置
  • 血流動力學監測裝置
  • 電生理學設備

第7章 區域和國家分析

  • 全球兒科介入性心臟病學市場各地區、業績及預測（2019-2024、2024-2029、2034）
  • 全球兒科介入性心臟病學市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 兒科介入性心臟病學市場：競爭格局
  • 兒科介入性心臟病學市場：公司簡介
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • WL Gore & Associates Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Siemens Healthineers
  • Numed Inc.
  • St. Jude Medical Inc.
  • Cordis Corporation
  • Koninklijke Philips NV
  • Biotronik
  • B. Braun Melsungen AG
  • Canon Medical Systems Corporation
  • Gore & Associates Inc.
  • Johnson and Johnson
  • Cook Group LLC
  • Teleflex Incorporated
  • Merit Medical Systems Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年兒科介入心臟病學市場：提供新機會的國家
  • 2029年兒科介入性心臟病學市場：細分領域帶來新機會
  • 2029年兒科介入性心臟病學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24398u

Pediatric interventional cardiology involves utilizing cardiac catheterization in children to both diagnose and treat congenital heart defects through minimally invasive procedures. These procedures aim to address various heart conditions while minimizing surgical invasiveness.

Key devices within pediatric interventional cardiology encompass closure devices, trans catheter heart valves, atherectomy devices, catheters, balloons, stents, among others. Closure devices encompass a range of fittings that, when securely fastened in a closed position, mitigate or prevent air emissions by sealing openings in containers or their exteriors. The primary procedures in pediatric interventional cardiology involve catheter-based valve implantation, correction of congenital heart defects, angioplasty, coronary thrombectomy, and other methodologies. These procedures find application in clinical testing labs, hospitals, cardiac centers, pediatric clinics, and research institutions, contributing significantly to diagnosing and managing cardiac conditions in children.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The pediatric interventional cardiology market research report is one of a series of new reports from The Business Research Company that provides pediatric interventional cardiology market statistics, including pediatric interventional cardiology industry global market size, regional shares, competitors with a pediatric interventional cardiology market share, detailed pediatric interventional cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric interventional cardiology industry. This pediatric interventional cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.44 billion in 2024 to $2.6 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased mycotoxin awareness, stringent regulatory standards, focus on animal health, globalization of poultry production, market competitiveness, increased farm productivity.

The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing poultry industry, climate change impacts, demand for organic products, global trade dynamics, government initiatives, increasing health consciousness. Major trends in the forecast period include integration of technology, feed quality and safety, market consolidation, collaborative research efforts, digitalization in agriculture, advancements in feed technology.

The forecast of 8.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher expenses for micro-guidewires and balloon-expandable stents, largely imported from the Netherlands and Japan, affecting minimally invasive cardiac procedures for children.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The pediatric interventional cardiology market is poised for growth due to the increasing prevalence of congenital heart disease, a condition affecting the heart's structure since birth. These procedures offer advantages over traditional open-heart surgery, including quicker recovery, reduced infection risks, and minimized scarring. According to the American Heart Association in 2022, around 40,000 infants in the U.S. are affected by congenital heart defects, with an estimated birth prevalence of 12.3 per 1000 in the country. Additionally, The Lancet reported in 2022 that congenital heart disease is the most common birth defect, impacting nearly 9 out of every 1000 live births. This prevalence is expected to drive the growth of the pediatric interventional cardiology market.

Pedistric population drives the pediatric interventional cardiology market going forward. This demographic refers to individuals within specific age brackets typically associated with childhood and adolescence. According to the Federal Interagency Forum on Child and Family Statistics, the U.S. had around 72.5 million children in 2022, projected to reach 78.2 million by 2050. The rise in this population, spanning different age groups, is expected to fuel the demand for pediatric interventional cardiology procedures.

Product innovation is a significant trend in the pediatric interventional cardiology market. Leading companies in this field are introducing new and creative solutions to enhance their market presence. For example, in February 2023, Medtronic plc., a U.S.-based medical devices company, launched the Harmony Transcatheter Pulmonary Valve System, a transcatheter pulmonary valve. This system serves as a minimally invasive alternative to open-heart surgery and can be implanted through a small incision in the leg or neck. The Harmony TPV system is designed for patients who have previously undergone surgery for congenital heart disease and are experiencing a dysfunctional right ventricular outflow tract (RVOT) due to an earlier implanted conduit or bioprosthetic pulmonary valve. It is also indicated for patients with a native or patched RVOT who need a pulmonary valve replacement.

Major companies in the pediatric interventional cardiology market are prioritizing the development of technological innovations, such as three-dimensional transesophageal echocardiography (3D TEE), to secure a competitive advantage. In pediatric interventional cardiology, real-time 3D TEE provides intricate images of congenital heart defects, including atrial and ventricular septal defects, which are vital for planning and guiding minimally invasive procedures. For example, in January 2024, Philips, a healthcare technology company based in the Netherlands, launched the X11-4T Mini 3D TEE transducer. This state-of-the-art transducer enhances three-dimensional transesophageal echocardiography (TEE) by delivering detailed imaging essential for diagnosing congenital heart defects in children. Notable features include its compact design, which improves maneuverability in pediatric patients, high-resolution imaging capabilities that boost diagnostic accuracy, and compatibility with existing echocardiography systems for a seamless workflow. These advancements substantially enhance procedural outcomes and patient care within pediatric cardiology.

In February 2022, Boston Scientific Corporation, a prominent U.S. biomedical and biotechnology firm, completed the acquisition of Baylis Medical Company Inc. for an estimated $1.75 billion. This strategic move is aimed at fortifying Boston Scientific Corporation's standing within the cardiology markets, specifically by enhancing its offerings in advanced solutions for catheter-based left-heart procedures. Baylis Medical Company Inc., also based in the U.S., specializes in cutting-edge medical devices operating within high-technology cardiology, endovascular, and oncology realms.

Major companies operating in the pediatric interventional cardiology market include Medtronic plc, GE HealthCare Technologies Inc., Abbott Laboratories, Terumo Corporation, W.L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Siemens Healthineers, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Canon Medical Systems Corporation, Gore & Associates Inc., Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co.Ltd., Biosensors International Group Ltd., Cardiac Science Corporation, Asahi Intecc Co.Ltd., Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH

North America was the largest region in the pediatric interventional cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pediatric interventional cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The pediatric interventional cardiology market includes revenues earned by entities by percutaneous coronary intervention services, atrial septal defect services, cardiac catheterization services, and trans catheter aortic valve replacement services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pediatric interventional cardiology market also consists of sales of plaque modification devices, guide wire, vascular closure devices, and atherectomy device. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Interventional Cardiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric interventional cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric interventional cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric interventional cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Closure Devices; Trans catheter Heart Valves; Atherectomy Devices; Catheters; Balloons; Stents; Other Device Types
  • 2) By Procedure: Catheter-Based Valve Implantation; Congenital Heart Defect Correction; Angioplasty; Coronary Thrombectomy; Other Procedures
  • 3) By End-Use: Clinical Testing Laboratories; Hospitals; Cardiac Centers; Pediatric Clinics; Research Institutions
  • Subsegments:
  • 1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices; Ventricular Septal Defect (VSD) Closure Devices; Patent Ductus Arteriosus (PDA) Closure Devices
  • 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR) Devices; Transcatheter Mitral Valve Repair Devices; Transcatheter Pulmonary Valve Replacement Devices
  • 3) By Atherectomy Devices: Directional Atherectomy Devices; Rotational Atherectomy Devices; Laser Atherectomy Devices
  • 4) By Catheters: Diagnostic Catheters; Therapeutic Catheters; Guiding Catheters
  • 5) By Balloons: Balloon Angioplasty Balloons; Intra-Aortic Balloons; High-Pressure Balloons
  • 6) By Stents: Drug-Eluting Stents; Bare-Metal Stents; Bioresorbable Stents
  • 7) By Other Device Types: Vascular Closure Devices; Hemodynamic Monitoring Devices; Electrophysiology Devices
  • Companies Mentioned: Medtronic plc; GE HealthCare Technologies Inc.; Abbott Laboratories; Terumo Corporation; W.L. Gore & Associates Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Siemens Healthineers; Numed Inc.; St. Jude Medical Inc.; Cordis Corporation; Koninklijke Philips N.V.; Biotronik; B. Braun Melsungen AG; Canon Medical Systems Corporation; Gore & Associates Inc.; Johnson and Johnson; Cook Group LLC; Teleflex Incorporated; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Lepu Medical Technology (Beijing) Co.Ltd.; Biosensors International Group Ltd.; Cardiac Science Corporation; Asahi Intecc Co.Ltd.; Medinol Ltd.; Jotec GmbH; Hexacath Ltd.; Translumina GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pediatric Interventional Cardiology Market Characteristics

3. Pediatric Interventional Cardiology Market Trends And Strategies

4. Pediatric Interventional Cardiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pediatric Interventional Cardiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pediatric Interventional Cardiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pediatric Interventional Cardiology Market Growth Rate Analysis
  • 5.4. Global Pediatric Interventional Cardiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pediatric Interventional Cardiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pediatric Interventional Cardiology Total Addressable Market (TAM)

6. Pediatric Interventional Cardiology Market Segmentation

  • 6.1. Global Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Closure Devices
  • Trans catheter Heart Valves
  • Atherectomy Devices
  • Catheters
  • Balloons
  • Stents
  • Other Device Types
  • 6.2. Global Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Catheter-Based Valve Implantation
  • Congenital Heart Defect Correction
  • Angioplasty
  • Coronary Thrombectomy
  • Other Procedures
  • 6.3. Global Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Testing Laboratories
  • Hospitals
  • Cardiac Centers
  • Pediatric Clinics
  • Research Institutions
  • 6.4. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Closure Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (ASD) Closure Devices
  • Ventricular Septal Defect (VSD) Closure Devices
  • Patent Ductus Arteriosus (PDA) Closure Devices
  • 6.5. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Transcatheter Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Aortic Valve Replacement (TAVR) Devices
  • Transcatheter Mitral Valve Repair Devices
  • Transcatheter Pulmonary Valve Replacement Devices
  • 6.6. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Atherectomy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Directional Atherectomy Devices
  • Rotational Atherectomy Devices
  • Laser Atherectomy Devices
  • 6.7. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Catheters
  • Therapeutic Catheters
  • Guiding Catheters
  • 6.8. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Angioplasty Balloons
  • Intra-Aortic Balloons
  • High-Pressure Balloons
  • 6.9. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioresorbable Stents
  • 6.10. Global Pediatric Interventional Cardiology Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vascular Closure Devices
  • Hemodynamic Monitoring Devices
  • Electrophysiology Devices

7. Pediatric Interventional Cardiology Market Regional And Country Analysis

  • 7.1. Global Pediatric Interventional Cardiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pediatric Interventional Cardiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Interventional Cardiology Market

  • 8.1. Asia-Pacific Pediatric Interventional Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Interventional Cardiology Market

  • 9.1. China Pediatric Interventional Cardiology Market Overview
  • 9.2. China Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Interventional Cardiology Market

  • 10.1. India Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Interventional Cardiology Market

  • 11.1. Japan Pediatric Interventional Cardiology Market Overview
  • 11.2. Japan Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Interventional Cardiology Market

  • 12.1. Australia Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Interventional Cardiology Market

  • 13.1. Indonesia Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Interventional Cardiology Market

  • 14.1. South Korea Pediatric Interventional Cardiology Market Overview
  • 14.2. South Korea Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Interventional Cardiology Market

  • 15.1. Western Europe Pediatric Interventional Cardiology Market Overview
  • 15.2. Western Europe Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Interventional Cardiology Market

  • 16.1. UK Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Interventional Cardiology Market

  • 17.1. Germany Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Interventional Cardiology Market

  • 18.1. France Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Interventional Cardiology Market

  • 19.1. Italy Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Interventional Cardiology Market

  • 20.1. Spain Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Interventional Cardiology Market

  • 21.1. Eastern Europe Pediatric Interventional Cardiology Market Overview
  • 21.2. Eastern Europe Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Interventional Cardiology Market

  • 22.1. Russia Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Interventional Cardiology Market

  • 23.1. North America Pediatric Interventional Cardiology Market Overview
  • 23.2. North America Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Interventional Cardiology Market

  • 24.1. USA Pediatric Interventional Cardiology Market Overview
  • 24.2. USA Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Interventional Cardiology Market

  • 25.1. Canada Pediatric Interventional Cardiology Market Overview
  • 25.2. Canada Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Interventional Cardiology Market

  • 26.1. South America Pediatric Interventional Cardiology Market Overview
  • 26.2. South America Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Interventional Cardiology Market

  • 27.1. Brazil Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Interventional Cardiology Market

  • 28.1. Middle East Pediatric Interventional Cardiology Market Overview
  • 28.2. Middle East Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Interventional Cardiology Market

  • 29.1. Africa Pediatric Interventional Cardiology Market Overview
  • 29.2. Africa Pediatric Interventional Cardiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pediatric Interventional Cardiology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pediatric Interventional Cardiology Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Interventional Cardiology Market Competitive Landscape And Company Profiles

  • 30.1. Pediatric Interventional Cardiology Market Competitive Landscape
  • 30.2. Pediatric Interventional Cardiology Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. W.L. Gore & Associates Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Interventional Cardiology Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Edwards Lifesciences Corporation
  • 31.3. Siemens Healthineers
  • 31.4. Numed Inc.
  • 31.5. St. Jude Medical Inc.
  • 31.6. Cordis Corporation
  • 31.7. Koninklijke Philips N.V.
  • 31.8. Biotronik
  • 31.9. B. Braun Melsungen AG
  • 31.10. Canon Medical Systems Corporation
  • 31.11. Gore & Associates Inc.
  • 31.12. Johnson and Johnson
  • 31.13. Cook Group LLC
  • 31.14. Teleflex Incorporated
  • 31.15. Merit Medical Systems Inc.

32. Global Pediatric Interventional Cardiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Interventional Cardiology Market

34. Recent Developments In The Pediatric Interventional Cardiology Market

35. Pediatric Interventional Cardiology Market High Potential Countries, Segments and Strategies

  • 35.1 Pediatric Interventional Cardiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pediatric Interventional Cardiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pediatric Interventional Cardiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer